A learning paradigm informed by knowledge of the learning self : a compendium of applied research on the Let Me Learn [Book review]

This research compendium was compiled to celebrate the 20th anniversary of the Let Me Learn Process®, Advanced Learning System and the US and Malta researchers who over the past two decades have conducted the researching and implementation of the Let Me Learn Process in the US, Australia, Malta and seven other EU member nations. The text was released during the International Learning Summit: Unlocking Learning Potential held in Sliema, Malta, July, 2015. It is edited by Dr. Colin Calleja, flag bearer for Let Me Learn- Malta and Europe, and Professor Christine Johnston, originator and lead researcher of Let Me Learn-USA.peer-reviewe

Apprendimento trasformativo: l’esperienza trasformativa del leader

A transformative leader is a person who inspires others to follow his or hervisionary position. Such a leader causes change in individuals and socialsystems. What follows is a narrative of a school leader whose inspirationand commitment brought about systemic change in the school he leads.Un leader trasformativo è una persona che ispira gli altri a seguire la propriaposizione visionaria. Tale leader provoca cambiamenti negli individui e neisistemi sociali. Quello che segue è il racconto di un leader di scuola, l’ispirazionee l’impegno del quale ha portato cambiamenti sistemici nella scuolache conduce

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.

S

withdrawn 2017 hrs ehra ecas aphrs solaece expert consensus statement on catheter and surgical ablation of atrial fibrillation

n/

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.

S

Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

We compared the serologic responses of one versus two doses of a variant vaccine (Moderna mRNA-1273 Beta/Omicron BA.1 bivalent vaccine) in adults. A two-dose boosting regimen with a variant vaccine did not increase the magnitude or the durability of the serological responses compared to a single variant vaccine boost

Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial

In a randomized clinical trial, we compare early neutralizing antibody responses after boosting with bivalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines based on either BA.1 or BA.4/BA.5 Omicron spike protein combined with wild-type spike. Responses against SARS-CoV-2 variants exhibited the greatest reduction in titers against currently circulating Omicron subvariants for both bivalent vaccines

Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.

We compared the serologic responses of one versus two doses of a variant vaccine (Moderna mRNA-1273 Beta/Omicron BA.1 bivalent vaccine) in adults. A two-dose boosting regimen with a variant vaccine did not increase the magnitude or the durability of the serological responses compared to a single variant vaccine boost